Showing 3,341 - 3,360 results of 6,051 for search '"the United States"', query time: 0.08s Refine Results
  1. 3341
  2. 3342
  3. 3343
  4. 3344
  5. 3345
  6. 3346
  7. 3347
  8. 3348
  9. 3349
  10. 3350
  11. 3351
  12. 3352
  13. 3353
  14. 3354
  15. 3355
  16. 3356
  17. 3357

    Painting a portrait: Analysis of national health survey data for cancer genetic counseling by Monica H. Stamp, Ora K. Gordon, Christopher P. Childers, Kimberly K. Childers

    Published 2019-03-01
    “…Results An estimated 4.8 million individuals in the United States had cancer genetic counseling. On bivariate analysis, there were significant differences in proportions undergoing genetic counseling by sex, race/ethnicity, insurance, citizenship, education, age, and cancer status (P < 0.01). …”
    Get full text
    Article
  18. 3358

    Association between folate and glutamine metabolism and prognosis of kidney cancer by Jiaxuan Qin, Jiaxuan Qin, Jiaxuan Qin, Jiaxuan Qin, Chaoyue Ouyang, Chaoyue Ouyang, Chaoyue Ouyang, Chaoyue Ouyang, Xuan Zhuang, Xuan Zhuang, Xuan Zhuang, Xuan Zhuang

    Published 2025-01-01
    “…Elevated levels of serum folate may be associated with improved CSS in kidney cancer patients in the United States.…”
    Get full text
    Article
  19. 3359

    A bibliometric analysis of exosomes in aging from 2007 to 2023 by Zenghui Niu, Meiyu Cui, Yingkun Fu, Lingfeng Zhou, Jiali Wang, Jiali Wang, Yan Lei, Xinrong Fan, Qiang Wang, Jing Yang

    Published 2025-01-01
    “…A total of 2,321 research institutions from 78 countries and regions were primarily led by China and the United States. Both Kapogiannis D and Goetzl E were active authors in this field. …”
    Get full text
    Article
  20. 3360

    In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram-Positive and Gram-Negative Bacterial Pathogens Isolated from Pa... by James A Karlowsky, Mel DeCorby, Daryl J Hoban, George G Zhanel

    Published 2009-01-01
    “…BACKGROUND: In 2008, ceftobiprole was approved by Health Canada for the treatment of patients with complicated skin and skin structure infections including diabetic foot infections; approval of ceftobiprole by the United States Food and Drug Administration is pending. …”
    Get full text
    Article